Multidrug Efflux Pumps in Bacteria and Efflux Pump Inhibitors

1 2019 antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, https://www.who.int/publications-detail-redirect/9789240000193 (2021) 2019 antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline https://www.who.int/publications-detail-redirect/9789240000193 2021 Search in Google Scholar

2 Kabra R., Chauhan N., Kumar A., Ingale P., Singh S.: Efflux pumps and antimicrobial resistance: Paradoxical components in systems genomics. Prog. Biophys. Mol. Biol. 141, 15–24 (2019) KabraR. ChauhanN. KumarA. IngaleP. SinghS. Efflux pumps and antimicrobial resistance: Paradoxical components in systems genomics Prog. Biophys. Mol. Biol. 141 15 24 2019 10.1016/j.pbiomolbio.2018.07.008 Search in Google Scholar

3 Reygaert W.C.: An overview of the antimicrobial resistance mechanisms of bacteria. AIMS. Microbiol. 4, 482–501 (2018) ReygaertW.C. An overview of the antimicrobial resistance mechanisms of bacteria AIMS. Microbiol. 4 482 501 2018 10.3934/microbiol.2018.3.482 Search in Google Scholar

4 Nikaido H.: Multiple antibiotic resistance and efflux. Curr. Opin. Microbiol. 1, 516–523 (1998) NikaidoH. Multiple antibiotic resistance and efflux Curr. Opin. Microbiol. 1 516 523 1998 10.1016/S1369-5274(98)80083-0 Search in Google Scholar

5 Langevin A.M., Dunlop M.J.: Stress introduction rate alters the benefit of AcrAB-TolCefflux pumps. J. Bacteriol. 200, e00525-17 (2017) LangevinA.M. DunlopM.J. Stress introduction rate alters the benefit of AcrAB-TolCefflux pumps J. Bacteriol. 200 e00525-17 2017 Search in Google Scholar

6 He X., Lu F., Yuan F., Jiang D., Zhao P., Zhu J., Cheng H., Cao J., Lu G.: Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the AdeFGH efflux pump. Antimicrob. Agents. Chemother. 59, 4817–4825 (2015) HeX. LuF. YuanF. JiangD. ZhaoP. ZhuJ. ChengH. CaoJ. LuG. Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the AdeFGH efflux pump Antimicrob. Agents. Chemother. 59 4817 4825 2015 10.1128/AAC.00877-15450522726033730 Search in Google Scholar

7 Favre-Bonté S., Köhler T., Van Delden C.: Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J. Antimicrob. Chemother. 52, 598–604 (2003) Favre-BontéS. KöhlerT. Van DeldenC. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin J. Antimicrob. Chemother. 52 598 604 2003 10.1093/jac/dkg39712951348 Search in Google Scholar

8 Schembri M.A., Kjaergaard K., Klemm P.: Global gene expression in Escherichia coli biofilms. Mol. Microbiol. 48, 253–267 (2003) SchembriM.A. KjaergaardK. KlemmP. Global gene expression in Escherichia coli biofilms Mol. Microbiol. 48 253 267 2003 10.1046/j.1365-2958.2003.03432.x12657059 Search in Google Scholar

9 Diggle S.P., Winzer K., Lazdunski A., Williams P., Cámara M.: Advancing the quorum in Pseudomonas aeruginosa: MvaT and the regulation of N-acylhomoserine lactone production and virulence gene expression. J. Bacteriol. 184, 2576–2586 (2002) DiggleS.P. WinzerK. LazdunskiA. WilliamsP. CámaraM. Advancing the quorum in Pseudomonas aeruginosa: MvaT and the regulation of N-acylhomoserine lactone production and virulence gene expression J. Bacteriol. 184 2576 2586 2002 10.1128/JB.184.10.2576-2586.200213501211976285 Search in Google Scholar

10 Thanassi D.G., Cheng L.W., Nikaido H.: Active efflux of bile salts by Escherichia coli. J. Bacteriol. 179, 2512–2518 (1997) ThanassiD.G. ChengL.W. NikaidoH. Active efflux of bile salts by Escherichia coli J. Bacteriol. 179 2512 2518 1997 10.1128/jb.179.8.2512-2518.19971789979098046 Search in Google Scholar

11 Taylor D.L., Bina X.R., Bina J.E.: Vibrio cholerae VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus. PloS One, 7, e38208 (2012) TaylorD.L. BinaX.R. BinaJ.E. Vibrio cholerae VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus PloS One 7 e38208 2012 10.1371/journal.pone.0038208336422522666485 Search in Google Scholar

12 Schindler B.D., Kaatz G.W.: Multi-drug efflux pumps of Gram-positive bacteria. Drug. Resist. Updat. Rev. Comment. Antimicrob. Anticancer. Chemother. 27, 1–13 (2016) SchindlerB.D. KaatzG.W. Multi-drug efflux pumps of Gram-positive bacteria Drug. Resist. Updat. Rev. Comment. Antimicrob. Anticancer. Chemother. 27 1 13 2016 Search in Google Scholar

13 Li X-Z., Plésiat P., Nikaido H.: The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337–418 (2015) LiX-Z. PlésiatP. NikaidoH. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria Clin. Microbiol. Rev. 28 337 418 2015 10.1128/CMR.00117-14440295225788514 Search in Google Scholar

14 Handzlik J., Matys A., Kieć-Kononowicz K.: Recent advances in Multi-Drug Resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus. Antibiotics, 2, 28–45 (2013) HandzlikJ. MatysA. Kieć-KononowiczK. Recent advances in Multi-Drug Resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus Antibiotics 2 28 45 2013 10.3390/antibiotics2010028 Search in Google Scholar

15 Sharma A., Gupta V.K., Pathania R.: Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian. J. Med. Res. 149, 129–145 (2019) SharmaA. GuptaV.K. PathaniaR. Efflux pump inhibitors for bacterial pathogens: From bench to bedside Indian. J. Med. Res. 149 129 145 2019 10.4103/ijmr.IJMR_2079_17 Search in Google Scholar

16 Auda I.G., Ali Salman I.M., Odah J.G.: Efflux pumps of Gram-negative bacteria in brief. Gene Reports, 100666 (2020) AudaI.G. Ali SalmanI.M. OdahJ.G. Efflux pumps of Gram-negative bacteria in brief Gene Reports 100666 2020 10.1016/j.genrep.2020.100666 Search in Google Scholar

17 Lubelski J., Konings W.N., Driessen A.J.M.: Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol. Rev. 71, 463–476 (2007) LubelskiJ. KoningsW.N. DriessenA.J.M. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria Microbiol. Mol. Biol. Rev. 71 463 476 2007 10.1128/MMBR.00001-07 Search in Google Scholar

18 Pao SS., Paulsen I.T., Saier M.H. Jr.: Major facilitator superfamily. Microbiol Mol. Biol. Rev. 62, 1–34 (1998) PaoSS. PaulsenI.T. SaierM.H.Jr. Major facilitator superfamily Microbiol Mol. Biol. Rev. 62 1 34 1998 10.1128/MMBR.62.1.1-34.1998 Search in Google Scholar

19 Kuroda T., Tsuchiya T.: Multidrug efflux transporters in the MATE family. Biochim. Biophys. Acta. BBA – Proteins. Proteomics. 1794, 763–768 (2009) KurodaT. TsuchiyaT. Multidrug efflux transporters in the MATE family Biochim. Biophys. Acta. BBA – Proteins. Proteomics. 1794 763 768 2009 10.1016/j.bbapap.2008.11.012 Search in Google Scholar

20 Jack D.L., Yang N.M., Saier M.H Jr.: The drug/metabolite transporter superfamily: The DMT superfamily. Eur. J. Biochem. 268, 3620–3639 (2001) JackD.L. YangN.M. SaierM.HJr. The drug/metabolite transporter superfamily: The DMT superfamily Eur. J. Biochem. 268 3620 3639 2001 10.1046/j.1432-1327.2001.02265.x Search in Google Scholar

21 Nikaido H., Takatsuka Y.: Mechanisms of RND multidrug efflux pumps. Biochim. Biophys. Acta. BBA – Proteins. Proteomics. 1794, 769–781 (2009) NikaidoH. TakatsukaY. Mechanisms of RND multidrug efflux pumps Biochim. Biophys. Acta. BBA – Proteins. Proteomics. 1794 769 781 2009 10.1016/j.bbapap.2008.10.004 Search in Google Scholar

22 Mi W., Li Y., Yoon S.H., Ernst R.K., Walz T., Liao M.: Structural basis of MsbA-mediated lipopolysaccharide transport. Nature, 549, 233–237 (2017) MiW. LiY. YoonS.H. ErnstR.K. WalzT. LiaoM. Structural basis of MsbA-mediated lipopolysaccharide transport Nature 549 233 237 2017 10.1038/nature23649 Search in Google Scholar

23 Higgins C.F.: ABC transporters: physiology, structure and mechanism – an overview. Res. Microbiol. 152, 205–210 (2001) HigginsC.F. ABC transporters: physiology, structure and mechanism – an overview Res. Microbiol. 152 205 210 2001 10.1016/S0923-2508(01)01193-7 Search in Google Scholar

24 Xiong J., Mao D., Liu L.: Research progress on the role of ABC transporters in the drug resistance mechanism of intractable epilepsy. BioMed. Res. Int. 2015, 1–10 (2015) XiongJ. MaoD. LiuL. Research progress on the role of ABC transporters in the drug resistance mechanism of intractable epilepsy BioMed. Res. Int. 2015 1 10 2015 10.1155/2015/194541460048326491660 Search in Google Scholar

25 Wilkens S.: Structure and mechanism of ABC transporters. F1000Prime. Rep. 7, 14 (2015) WilkensS. Structure and mechanism of ABC transporters F1000Prime. Rep. 7 14 2015 10.12703/P7-14433884225750732 Search in Google Scholar

26 van Veen H.W., Venema K., Bolhuis H., Oussenko I., Kok J., Poolman B., Driessen A.J., Konings W.N.: Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA, 93, 10668–10672 (1996) van VeenH.W. VenemaK. BolhuisH. OussenkoI. KokJ. PoolmanB. DriessenA.J. KoningsW.N. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1 Proc. Natl. Acad. Sci. USA 93 10668 10672 1996 10.1073/pnas.93.20.10668382128855237 Search in Google Scholar

27 Dalmas O., Do Cao M-A., Lugo M.R., Sharom F.J., Di Pietro A., Jault M.A.: Time-resolved fluorescence resonance energy transfer shows that the bacterial multidrug ABC half-transporter BmrA functions as a homodimer. Biochemistry, 44, 4312–4321 (2005) DalmasO. Do CaoM-A. LugoM.R. SharomF.J. Di PietroA. JaultM.A. Time-resolved fluorescence resonance energy transfer shows that the bacterial multidrug ABC half-transporter BmrA functions as a homodimer Biochemistry 44 4312 4321 2005 10.1021/bi048280915766260 Search in Google Scholar

28 Fitzpatrick A.W.P., Du D. et al.: Structure of the MacAB-TolC ABC-type tripartite multidrug efflux pump. Nat. Microbiol. 2, 17070 (2017) FitzpatrickA.W.P. DuD. Structure of the MacAB-TolC ABC-type tripartite multidrug efflux pump Nat. Microbiol. 2 17070 2017 10.1038/nmicrobiol.2017.70544782128504659 Search in Google Scholar

29 Choudhuri B.S., Bhakta S., Barik R., Basu J., Kundu M., Chakrabarti P.: Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem. J. 367, 279–285 (2002) ChoudhuriB.S. BhaktaS. BarikR. BasuJ. KunduM. ChakrabartiP. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis Biochem. J. 367 279 285 2002 10.1042/bj20020615 Search in Google Scholar

30 Robertson G.T., Doyle T.B., Lynch A.S.: Use of an efflux-deficient Streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents. Antimicrob. Agents. Chemother. 49, 4781–4783 (2005) RobertsonG.T. DoyleT.B. LynchA.S. Use of an efflux-deficient Streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents Antimicrob. Agents. Chemother. 49 4781 4783 2005 10.1128/AAC.49.11.4781-4783.2005128015616251330 Search in Google Scholar

31 Hürlimann L.M., Corradi V., Hohl M., Bloemberg G.V., Tieleman D.P., Seeger M.A.: The heterodimeric ABC transporter EfrCD mediates multidrug efflux in Enterococcus faecalis. Antimicrob. Agents. Chemother. 60, 5400–5411 (2016) HürlimannL.M. CorradiV. HohlM. BloembergG.V. TielemanD.P. SeegerM.A. The heterodimeric ABC transporter EfrCD mediates multidrug efflux in Enterococcus faecalis Antimicrob. Agents. Chemother. 60 5400 5411 2016 10.1128/AAC.00661-16499786027381387 Search in Google Scholar

32 Al-Hamad A., Upton M., Burnie J.: Molecular cloning and characterization of SmrA, a novel ABC multi-drug efflux pump from Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 64, 731–734 (2009) Al-HamadA. UptonM. BurnieJ. Molecular cloning and characterization of SmrA, a novel ABC multi-drug efflux pump from Stenotrophomonas maltophilia J. Antimicrob. Chemother. 64 731 734 2009 10.1093/jac/dkp27119643774 Search in Google Scholar

33 Matsuo T., Chen J., Minato Y., Ogawa W., Mizushima T., Kuroda T., Tsuchiya T.: SmdAB, a heterodimeric ABC-type multi-drug efflux pump, in Serratia marcescens. J. Bacteriol. 190, 648–654 (2008) MatsuoT. ChenJ. MinatoY. OgawaW. MizushimaT. KurodaT. TsuchiyaT. SmdAB, a heterodimeric ABC-type multi-drug efflux pump, in Serratia marcescens J. Bacteriol. 190 648 654 2008 10.1128/JB.01513-07222369118024518 Search in Google Scholar

34 Huda N., Lee E-W., Chen J., Morita Y., Kuroda T., Mizushima T., Tsuchiya T.: Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in non-O1 Vibrio cholerae. Antimicrob. Agents. Chemother. 47, 413–2417 (2003) HudaN. LeeE-W. ChenJ. MoritaY. KurodaT. MizushimaT. TsuchiyaT. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in non-O1 Vibrio cholerae Antimicrob. Agents. Chemother. 47 413 2417 2003 10.1128/AAC.47.8.2413-2417.2003 Search in Google Scholar

35 Feng Z., Liu D., Liu Z., Liang Y., Wang Y., Liu Q., Liu Z., Zang Z., Cui Y.: Cloning and functional characterization of putative Escherichia coli ABC multidrug efflux transporter YddA. J. Microbiol. Biotechnol. 30, 982–995 (2020) FengZ. LiuD. LiuZ. LiangY. WangY. LiuQ. LiuZ. ZangZ. CuiY. Cloning and functional characterization of putative Escherichia coli ABC multidrug efflux transporter YddA J. Microbiol. Biotechnol. 30 982 995 2020 10.4014/jmb.2003.03003 Search in Google Scholar

36 Quistgaard E.M., Löw C., Guettou F., Nordlund P.: Understanding transport by the major facilitator superfamily (MFS): structures pave the way. Nat. Rev. Mol. Cell. Biol. 17, 123–132 (2016) QuistgaardE.M. LöwC. GuettouF. NordlundP. Understanding transport by the major facilitator superfamily (MFS): structures pave the way Nat. Rev. Mol. Cell. Biol. 17 123 132 2016 10.1038/nrm.2015.25 Search in Google Scholar

37 Ren Q., Chen K., Paulsen I.T.: TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic. Acids. Res. 35, D274–D279 (2007) RenQ. ChenK. PaulsenI.T. TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels Nucleic. Acids. Res. 35 D274 D279 2007 10.1093/nar/gkl925 Search in Google Scholar

38 Henderson P.J.: The 12-transmembrane helix transporters. Curr. Opin. Cell. Biol. 5, 708–721 (1993) HendersonP.J. The 12-transmembrane helix transporters Curr. Opin. Cell. Biol. 5 708 721 1993 10.1016/0955-0674(93)90144-F Search in Google Scholar

39 Edgar R., Bibi E.: MdfA, an Escherichia coli multi-drug resistance protein with an extraordinarily broad spectrum of drug recognition. J. Bacteriol. 179, 2274 (1997) EdgarR. BibiE. MdfA, an Escherichia coli multi-drug resistance protein with an extraordinarily broad spectrum of drug recognition J. Bacteriol. 179 2274 1997 10.1128/jb.179.7.2274-2280.19971789649079913 Search in Google Scholar

40 Putman M., van Veen H.W., Degener J.E., Konings W.N.: The lactococcal secondary multidrug transporter LmrP confers resistance to lincosamides, macrolides, streptogramins and tetracyclines. Microbiology, 147, 2873–2880 (2001) PutmanM. van VeenH.W. DegenerJ.E. KoningsW.N. The lactococcal secondary multidrug transporter LmrP confers resistance to lincosamides, macrolides, streptogramins and tetracyclines Microbiology 147 2873 2880 2001 10.1099/00221287-147-10-287311577166 Search in Google Scholar

41 Fontaine F., Hequet A., Voisin-Chiret A.S., Bouillon A., Lesnard A., Cresteil T., Jolivalt C., Rault S.: First identification of boronic species as novel potential inhibitors of the Staphylococcus aureusNorA efflux pump. J. Med. Chem. 57, 2536–2548 (2014) FontaineF. HequetA. Voisin-ChiretA.S. BouillonA. LesnardA. CresteilT. JolivaltC. RaultS. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureusNorA efflux pump J. Med. Chem. 57 2536 2548 2014 10.1021/jm401808n24499135 Search in Google Scholar

42 Bolhuis H., van Veen H.W., Poolman B., Driessen A.J., Konings W.N.: Mechanisms of multidrug transporters. FEMS. Microbiol. Rev. 21, 55–84 (1997) BolhuisH. van VeenH.W. PoolmanB. DriessenA.J. KoningsW.N. Mechanisms of multidrug transporters FEMS. Microbiol. Rev. 21 55 84 1997 10.1111/j.1574-6976.1997.tb00345.x9299702 Search in Google Scholar

43 Li X.Z., Nikaido H.: Efflux-mediated drug resistance in bacteria: an update. Drugs, 69, 1555–1623 (2009) LiX.Z. NikaidoH. Efflux-mediated drug resistance in bacteria: an update Drugs 69 1555 1623 2009 10.2165/11317030-000000000-00000284739719678712 Search in Google Scholar

44 Alav I., Kobylka J., Kuth M.S., Pos K.M., Picard M., Blair J.M.A., Bavro V.N.: Structure, assembly, and function of tripartite efflux and type 1 secretion systems in Gram-negative bacteria. Chem. Rev. 121, 5479–5596 (2021) AlavI. KobylkaJ. KuthM.S. PosK.M. PicardM. BlairJ.M.A. BavroV.N. Structure, assembly, and function of tripartite efflux and type 1 secretion systems in Gram-negative bacteria Chem. Rev. 121 5479 5596 2021 10.1021/acs.chemrev.1c00055827710233909410 Search in Google Scholar

45 Leung Y.M., Holdbrook D.A., Piggot T.J., Khalid S.: The NorM MATE transporter from N. gonorrhoeae: insights into drug and ion binding from atomistic molecular dynamics simulations. Biophys. J. 107, 460–468 (2014) LeungY.M. HoldbrookD.A. PiggotT.J. KhalidS. The NorM MATE transporter from N. gonorrhoeae: insights into drug and ion binding from atomistic molecular dynamics simulations Biophys. J. 107 460 468 2014 10.1016/j.bpj.2014.06.005410406025028887 Search in Google Scholar

46 Radchenko M., Symersky J., Nie R., Lu M.: Structural basis for the blockade of MATE multidrug efflux pumps. Nat. Commun. 6, 1–11 (2015) RadchenkoM. SymerskyJ. NieR. LuM. Structural basis for the blockade of MATE multidrug efflux pumps Nat. Commun. 6 1 11 2015 10.1038/ncomms8995486660026246409 Search in Google Scholar

47 Morita Y., Kodama K., Shiota S., Mine T., Kataoka A., Mizushima T., Tsuchiya T.: NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents. Chemother. 42, 5 (1998) MoritaY. KodamaK. ShiotaS. MineT. KataokaA. MizushimaT. TsuchiyaT. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli Antimicrob. Agents. Chemother. 42 5 1998 10.1128/AAC.42.7.17781056829661020 Search in Google Scholar

48 Kusakizako T., Miyauchi H., Ishitani R., Nureki O.: Structural biology of the multidrug and toxic compound extrusion superfamily transporters. Biochim. Biophys. Acta. BBA – Biomembr. 1862, 183154 (2020) KusakizakoT. MiyauchiH. IshitaniR. NurekiO. Structural biology of the multidrug and toxic compound extrusion superfamily transporters Biochim. Biophys. Acta. BBA – Biomembr. 1862 183154 2020 10.1016/j.bbamem.2019.18315431866287 Search in Google Scholar

49 Kaatz G.W., McAleese F., Seo S.M.: Multi-drug resistance in Staphylococcus aureus due to overexpression of a novel multi-drug and toxin extrusion (MATE) transport protein. Anti microb. Agents.Chemother. 49, 1857–1864 (2005) KaatzG.W. McAleeseF. SeoS.M. Multi-drug resistance in Staphylococcus aureus due to overexpression of a novel multi-drug and toxin extrusion (MATE) transport protein Anti microb. Agents.Chemother. 49 1857 1864 2005 10.1128/AAC.49.5.1857-1864.2005108764315855507 Search in Google Scholar

50 McAleese F., Petersen P., Ruzin A., Dunman PM., Murphy E., Projan SJ., Bradford PA.: A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob. Agents. Chemother. 49, 1865–1871 (2005) McAleeseF. PetersenP. RuzinA. DunmanPM. MurphyE. ProjanSJ. BradfordPA. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline Antimicrob. Agents. Chemother. 49 1865 1871 2005 10.1128/AAC.49.5.1865-1871.2005108764415855508 Search in Google Scholar

51 Tanihara Y., Masuda S., Sato T., Katsura T., Ogawa O., Inui K.: Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem. Pharmacol. 74, 359–371 (2007) TaniharaY. MasudaS. SatoT. KatsuraT. OgawaO. InuiK. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters Biochem. Pharmacol. 74 359 371 2007 10.1016/j.bcp.2007.04.01017509534 Search in Google Scholar

52 He G.X., Kuroda T., Mima T., Morita Y., Mizushima T., Tsuchiya T.: An H(+)–coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J. Bacteriol. 186, 262–265 (2004) HeG.X. KurodaT. MimaT. MoritaY. MizushimaT. TsuchiyaT. An H(+)–coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa J. Bacteriol. 186 262 265 2004 10.1128/JB.186.1.262-265.200430344914679249 Search in Google Scholar

53 Heir E., Sundheim G., Holck A.L.: The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry. J. Appl. Microbiol. 86, 378–388 (1999) HeirE. SundheimG. HolckA.L. The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry J. Appl. Microbiol. 86 378 388 1999 10.1046/j.1365-2672.1999.00672.x10196743 Search in Google Scholar

54 Bay D.C., Rommens K.L., Turner R.J.: Small multi-drug resistance proteins: A multi-drug transporter family that continues to grow. Biochim. Biophys. Acta. BBA – Biomembr. 1778, 1814–1838 (2008) BayD.C. RommensK.L. TurnerR.J. Small multi-drug resistance proteins: A multi-drug transporter family that continues to grow Biochim. Biophys. Acta. BBA – Biomembr. 1778 1814 1838 2008 10.1016/j.bbamem.2007.08.01517942072 Search in Google Scholar

55 Paulsen I.T., Skurray R.A., Tam R., Saier M.H. Jr., Turner R.J., Weiner J.H., Goldberg E.B., Grinius L.L.: The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 19, 1167–1175 (1996) PaulsenI.T. SkurrayR.A. TamR. SaierM.H.Jr. TurnerR.J. WeinerJ.H. GoldbergE.B. GriniusL.L. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs Mol. Microbiol. 19 1167 1175 1996 10.1111/j.1365-2958.1996.tb02462.x8730859 Search in Google Scholar

56 Yerushalmi H., Lebendiker M., Schuldiner S.: EmrE, an Escherichia coli 12-kDa multidrug transporter, exchanges toxic cations and H⁺ and is soluble in organic solvents. J. Biol. Chem. 270, 6856–6863 (1995) YerushalmiH. LebendikerM. SchuldinerS. EmrE, an Escherichia coli 12-kDa multidrug transporter, exchanges toxic cations and H⁺ and is soluble in organic solvents J. Biol. Chem. 270 6856 6863 1995 10.1074/jbc.270.12.68567896833 Search in Google Scholar

57 Choudhary S., Sar P.: Real-time PCR based analysis of metal resistance genes in metal resistant Pseudomonas aeruginosa strain J007: Real-time PCR-based analysis of metal resistance genes. J. Basic. Microbiol. 56, 688–697 (2016) ChoudharyS. SarP. Real-time PCR based analysis of metal resistance genes in metal resistant Pseudomonas aeruginosa strain J007: Real-time PCR-based analysis of metal resistance genes J. Basic. Microbiol. 56 688 697 2016 10.1002/jobm.20150036426662317 Search in Google Scholar

58 Magnet S., Courvalin P., Lambert T.: Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents. Chemother. 45, 3375–3380 (2001) MagnetS. CourvalinP. LambertT. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 Antimicrob. Agents. Chemother. 45 3375 3380 2001 10.1128/AAC.45.12.3375-3380.20019084011709311 Search in Google Scholar

59 Xu C., Bilya S.R., Xu W.: adeABC efflux gene in Acinetobacter baumannii. New. Microbes. New. Infect. 30, 100549 (2019) XuC. BilyaS.R. XuW. adeABC efflux gene in Acinetobacter baumannii New. Microbes. New. Infect. 30 100549 2019 10.1016/j.nmni.2019.100549653568931193498 Search in Google Scholar

60 Piddock L.J.V.: Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382–402 (2006) PiddockL.J.V. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria Clin. Microbiol. Rev. 19 382 402 2006 10.1128/CMR.19.2.382-402.2006147198916614254 Search in Google Scholar

61 Nakashima R., Sakurai K., Yamasaki S., Nishino K., Yamaguchi A.: Structures of the multi-drug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature, 480, 565–569 (2011) NakashimaR. SakuraiK. YamasakiS. NishinoK. YamaguchiA. Structures of the multi-drug exporter AcrB reveal a proximal multisite drug-binding pocket Nature 480 565 569 2011 10.1038/nature1064122121023 Search in Google Scholar

62 Du D., Wang Z., James N.R., Voss J.E., Klimont E., Ohene-Agyei T., Venter H., Chiu W., Luisi B.F.: Structure of the AcrAB-TolC multidrug efflux pump. Nature, 509, 512–515 (2014) DuD. WangZ. JamesN.R. VossJ.E. KlimontE. Ohene-AgyeiT. VenterH. ChiuW. LuisiB.F. Structure of the AcrAB-TolC multidrug efflux pump Nature 509 512 515 2014 10.1038/nature13205436190224747401 Search in Google Scholar

63 Li X.Z., Livermore D.M., Nikaido H.: Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents. Chemother. 38, 1732–1741 (1994) LiX.Z. LivermoreD.M. NikaidoH. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin Antimicrob. Agents. Chemother. 38 1732 1741 1994 10.1128/AAC.38.8.17322846307986003 Search in Google Scholar

64 Tsukazaki T.: Structure-based working model of SecDF, a proton-driven bacterial protein translocation factor. FEMS. Microbiol. Lett. 365, 112 (2018) TsukazakiT. Structure-based working model of SecDF, a proton-driven bacterial protein translocation factor FEMS. Microbiol. Lett. 365 112 2018 10.1093/femsle/fny112597478929718185 Search in Google Scholar

65 Alcalde-Rico M, Hernando-Amado S, Blanco P, Martínez J.L.: Multidrug efflux pumps at the crossroad between antibiotic resistance and bacterial virulence. Front. Microbiol. 7, 1483 (2016) Alcalde-RicoM Hernando-AmadoS BlancoP MartínezJ.L. Multidrug efflux pumps at the crossroad between antibiotic resistance and bacterial virulence Front. Microbiol. 7 1483 2016 10.3389/fmicb.2016.01483503025227708632 Search in Google Scholar

66 Soto S.M.: Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence, 4, 223–229 (2013) SotoS.M. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm Virulence 4 223 229 2013 10.4161/viru.23724371198023380871 Search in Google Scholar

67 Liao J., Schurr M.J., Sauer K.: The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J. Bacteriol. 195, 3352–3363 (2013) LiaoJ. SchurrM.J. SauerK. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms J. Bacteriol. 195 3352 3363 2013 10.1128/JB.00318-13371954023687276 Search in Google Scholar

68 Houry A., Gohar M., Deschamps J., Tischenko E., Aymerich S., Gruss A., Briandet R.: Bacterial swimmers that infiltrate and take over the biofilm matrix. Proc. Natl. Acad. Sci. 109, 13088–1309313 (2012) HouryA. GoharM. DeschampsJ. TischenkoE. AymerichS. GrussA. BriandetR. Bacterial swimmers that infiltrate and take over the biofilm matrix Proc. Natl. Acad. Sci. 109 13088 1309313 2012 10.1073/pnas.1200791109342016222773813 Search in Google Scholar

69 Lin Y.T., Huang Y.W., Chen S.J., Chang C.W., Yang T.C.: The SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice. Antimicrob. Agents. Chemother. 59, 4067–4073 (2015) LinY.T. HuangY.W. ChenS.J. ChangC.W. YangT.C. The SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice Antimicrob. Agents. Chemother. 59 4067 4073 2015 10.1128/AAC.00372-15446872125918140 Search in Google Scholar

70 Linares J.F., López J.A., Camafeita E., Albar J.P., Rojo F., Martínez J.L.: Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J. Bacteriol. 187, 1384–1391 (2005) LinaresJ.F. LópezJ.A. CamafeitaE. AlbarJ.P. RojoF. MartínezJ.L. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa J. Bacteriol. 187 1384 1391 2005 10.1128/JB.187.4.1384-1391.200554560815687203 Search in Google Scholar

71 Tang M., Wei X., Wan X., Ding Z., Ding Y., Liu J.: The role and relationship with efflux pump of biofilm formation in Klebsiella pneumoniae. Microb. Pathog. 147, 104244 (2020) TangM. WeiX. WanX. DingZ. DingY. LiuJ. The role and relationship with efflux pump of biofilm formation in Klebsiella pneumoniae Microb. Pathog. 147 104244 2020 10.1016/j.micpath.2020.10424432437832 Search in Google Scholar

72 Sánchez P., Linares J.F., Ruiz-Díez B., Campanario E., Navas A., Baquero F., Martínez J.L.: Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J. Antimicrob. Chemother. 50, 657–664 (2002) SánchezP. LinaresJ.F. Ruiz-DíezB. CampanarioE. NavasA. BaqueroF. MartínezJ.L. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants J. Antimicrob. Chemother. 50 657 664 2002 10.1093/jac/dkf18512407121 Search in Google Scholar

73 Alav I., Sutton J.M., Rahman K.M.: Role of bacterial efflux pumps in biofilm formation. J. Antimicrob. Chemother. 73, 2003–2020 (2018) AlavI. SuttonJ.M. RahmanK.M. Role of bacterial efflux pumps in biofilm formation J. Antimicrob. Chemother. 73 2003 2020 2018 10.1093/jac/dky04229506149 Search in Google Scholar

74 Akinpelu S., Ajayi A., Smith S.I., Adeleye A.I.: Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital. BMC Res. Notes. 13, 1–5 (2020) AkinpeluS. AjayiA. SmithS.I. AdeleyeA.I. Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital BMC Res. Notes. 13 1 5 2020 10.1186/s13104-020-05105-2724940732456668 Search in Google Scholar

75 Pasqua M., Grossi M., Zennaro A., Fanelli G., Micheli G., Barras F., Colonna B., Prosseda G.: The varied role of efflux pumps of the MFS family in the interplay of bacteria with animal and plant cells. Microorganisms, 7, e285 (2019) PasquaM. GrossiM. ZennaroA. FanelliG. MicheliG. BarrasF. ColonnaB. ProssedaG. The varied role of efflux pumps of the MFS family in the interplay of bacteria with animal and plant cells Microorganisms 7 e285 2019 10.3390/microorganisms7090285678098531443538 Search in Google Scholar

76 Scoffone V.C., Trespidi G., Barbieri G., Irudal S., Perrin E., Buroni S.: Role of RND efflux pumps in drug resistance of cystic fibrosis pathogens. Antibiot. Basel. Switz. 10, 863 (2021) ScoffoneV.C. TrespidiG. BarbieriG. IrudalS. PerrinE. BuroniS. Role of RND efflux pumps in drug resistance of cystic fibrosis pathogens Antibiot. Basel. Switz. 10 863 2021 10.3390/antibiotics10070863830070434356783 Search in Google Scholar

77 Ugwuanyi F.C., Ajayi A., Ojo D.A., Adeleye A.I., Smith S.I.: Evaluation of efflux pump activity and biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa isolated from a Federal Medical Center in Nigeria. Ann. Clin. Microbiol. Antimicrob. 20, 11 (2021) UgwuanyiF.C. AjayiA. OjoD.A. AdeleyeA.I. SmithS.I. Evaluation of efflux pump activity and biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa isolated from a Federal Medical Center in Nigeria Ann. Clin. Microbiol. Antimicrob. 20 11 2021 10.1186/s12941-021-00417-y785218933531042 Search in Google Scholar

78 Holling N., Jones B.V. et al.: Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis. Infect. Immun. 82, 1616–1626 (2014) HollingN. JonesB.V. Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis Infect. Immun. 82 1616 1626 2014 10.1128/IAI.01652-13399340324470471 Search in Google Scholar

79 Baugh S., Ekanayaka A.S., Piddock L.J., Webber M.A.: Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. J. Antimicrob. Chemother. 67, 2409–2417 (2012) BaughS. EkanayakaA.S. PiddockL.J. WebberM.A. Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm J. Antimicrob. Chemother. 67 2409 2417 2012 10.1093/jac/dks22822733653 Search in Google Scholar

80 Krzyżek P., Grande R., Migdał P., Paluch E., Gościniak G.: Biofilm formation as a complex result of virulence and adaptive responses of Helicobacter pylori. Pathogens, 9, 1062 (2020) KrzyżekP. GrandeR. MigdałP. PaluchE. GościniakG. Biofilm formation as a complex result of virulence and adaptive responses of Helicobacter pylori Pathogens 9 1062 2020 10.3390/pathogens9121062776604433353223 Search in Google Scholar

81 Kvist M., Hancock V., Klemm P.: Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl. Environ. Microbiol. 74, 7376–7382 (2008) KvistM. HancockV. KlemmP. Inactivation of efflux pumps abolishes bacterial biofilm formation Appl. Environ. Microbiol. 74 7376 7382 2008 10.1128/AEM.01310-08259291218836028 Search in Google Scholar

82 Magesh H., Kumar A., Alam A., Priyam., Sekar U., Sumantran V.N., Vaidyanathan R.: Identification of natural compounds which inhibit biofilm formation in clinical isolates of Klebsiella pneumoniae. Indian. J. Exp. Biol. 51, 764–772 (2013) MageshH. KumarA. AlamA. Priyam SekarU. SumantranV.N. VaidyanathanR. Identification of natural compounds which inhibit biofilm formation in clinical isolates of Klebsiella pneumoniae Indian. J. Exp. Biol. 51 764 772 2013 Search in Google Scholar

83 Rampioni G., Pillai C.R., Longo F., Bondì R., Baldelli V., Messina M., Imperi F., Visca P., Leoni L.: Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence. Sci. Rep. 7, 11392 (2017) RampioniG. PillaiC.R. LongoF. BondìR. BaldelliV. MessinaM. ImperiF. ViscaP. LeoniL. Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence Sci. Rep. 7 11392 2017 10.1038/s41598-017-11892-9559601328900249 Search in Google Scholar

84 Casalone E., Vignolini T., Braconi L., Gardini L., Capitanio M., Pavone F.S., Dei S., Teodori E.: 1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in Escherichia coli. Future. Microbiol. 15, 987–999 (2020) CasaloneE. VignoliniT. BraconiL. GardiniL. CapitanioM. PavoneF.S. DeiS. TeodoriE. 1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in Escherichia coli Future. Microbiol. 15 987 999 2020 10.2217/fmb-2019-029632840130 Search in Google Scholar

85 Fleeman R.M., Debevec G., Antonen K., Adams J.L., Santos R.G., Welmaker G.S., Houghten R.A., Giulianotti M.A., Shaw L.N.: Identification of a novel polyamine scaffold with potent efflux pump inhibition activity toward multi-drug resistant bacterial pathogens. Front. Microbiol. 9, 1301 (2018) FleemanR.M. DebevecG. AntonenK. AdamsJ.L. SantosR.G. WelmakerG.S. HoughtenR.A. GiulianottiM.A. ShawL.N. Identification of a novel polyamine scaffold with potent efflux pump inhibition activity toward multi-drug resistant bacterial pathogens Front. Microbiol. 9 1301 2018 10.3389/fmicb.2018.01301601054529963035 Search in Google Scholar

86 Zimmermann S., Klinger-Strobel M., Bohnert J.A., Wendler S., Rödel J., Pletz M.W., Löffler B., Tuchscherr L.: Clinically approved drugs inhibit the Staphylococcus aureus multidrug NorA efflux pump and reduce biofilm formation. Front. Microbiol. 10, 2762 (2019) ZimmermannS. Klinger-StrobelM. BohnertJ.A. WendlerS. RödelJ. PletzM.W. LöfflerB. TuchscherrL. Clinically approved drugs inhibit the Staphylococcus aureus multidrug NorA efflux pump and reduce biofilm formation Front. Microbiol. 10 2762 2019 10.3389/fmicb.2019.02762690166731849901 Search in Google Scholar

87 Mahey N., Tambat R., Verma D.K., Chandal N., Thakur K.G., Nandanwar H.: Antifungal azoles as tetracycline resistance modifiers in Staphylococcus aureus. Appl. Environ. Microbiol. 87, e00155–21 (2021) MaheyN. TambatR. VermaD.K. ChandalN. ThakurK.G. NandanwarH. Antifungal azoles as tetracycline resistance modifiers in Staphylococcus aureus Appl. Environ. Microbiol. 87 e00155 21 2021 10.1128/AEM.00155-21827681033990311 Search in Google Scholar

88 Nzakizwanayo J., Jones B.V. et al.: Fluoxetine and thioridazine inhibit efflux and attenuate crystalline biofilm formation by Proteus mirabilis. Sci. Rep. 7, 12222 (2017) NzakizwanayoJ. JonesB.V. Fluoxetine and thioridazine inhibit efflux and attenuate crystalline biofilm formation by Proteus mirabilis Sci. Rep. 7 12222 2017 10.1038/s41598-017-12445-w561033728939900 Search in Google Scholar

89 Chevalier J., Mahamoud A., Baitiche M., Adam E., Viveiros M., Smarandache A., Militaru A., Pascu M.L., Amaral L., Pagès J.M.: Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains. Int. J. Antimicrob. Agents. 36, 164–168 (2010) ChevalierJ. MahamoudA. BaiticheM. AdamE. ViveirosM. SmarandacheA. MilitaruA. PascuM.L. AmaralL. PagèsJ.M. Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains Int. J. Antimicrob. Agents. 36 164 168 2010 10.1016/j.ijantimicag.2010.03.02720494558 Search in Google Scholar

90 Lomovskaya O., Lee V.J. et al.: Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother. 45, 105–116 (2001) LomovskayaO. LeeV.J. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy Antimicrob Agents Chemother. 45 105 116 2001 10.1128/AAC.45.1.105-116.20019024711120952 Search in Google Scholar

91 Siriyong T., Srimanote P., Chusri S., Yingyongnarongkul B.E., Suaisom C., Tipmanee V., Voravuthikunchai S.P.: Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. BMC. Complement. Altern. Med. 17, 405 (2017) SiriyongT. SrimanoteP. ChusriS. YingyongnarongkulB.E. SuaisomC. TipmaneeV. VoravuthikunchaiS.P. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa BMC. Complement. Altern. Med. 17 405 2017 10.1186/s12906-017-1913-y555731028806947 Search in Google Scholar

92 Osei Sekyere J., Amoako D.G.: Carbonyl cyanide m-chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae. Front. Microbiol. 8, 228 (2017) Osei SekyereJ. AmoakoD.G. Carbonyl cyanide m-chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae Front. Microbiol. 8 228 2017 10.3389/fmicb.2017.00228530628228261184 Search in Google Scholar

93 Adabi M., Talebi-Taher M., Arbabi L., Afshar M., Fathizadeh S., Minaeian S., Moghadam-Maragheh N., Majidpour A.: Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa by using an efflux pump inhibitor. Infect Chemother. 47, 98–104 (2015) AdabiM. Talebi-TaherM. ArbabiL. AfsharM. FathizadehS. MinaeianS. Moghadam-MaraghehN. MajidpourA. Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa by using an efflux pump inhibitor Infect Chemother. 47 98 104 2015 10.3947/ic.2015.47.2.98449528126157587 Search in Google Scholar

94 Ikonomidis A., Tsakris A., Kanellopoulou M., Maniatis A.N., Pournaras S.: Effect of the proton motive force inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) on Pseudomonas aeruginosa biofilm development. Lett. Appl. Cccp Microbiol. 47, 298–302 (2008) IkonomidisA. TsakrisA. KanellopoulouM. ManiatisA.N. PournarasS. Effect of the proton motive force inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) on Pseudomonas aeruginosa biofilm development Lett. Appl. Cccp Microbiol. 47 298 302 2008 10.1111/j.1472-765X.2008.02430.x Search in Google Scholar

95 Durães F., Resende D.I.S.P., Palmeira A., Szemerédi N., Pinto M.M.M., Spengler G., Sousa E.: Xanthones active against multidrug resistance and virulence mechanisms of bacteria. Antibiotics, 10, 600 (2021) DurãesF. ResendeD.I.S.P. PalmeiraA. SzemerédiN. PintoM.M.M. SpenglerG. SousaE. Xanthones active against multidrug resistance and virulence mechanisms of bacteria Antibiotics 10 600 2021 10.3390/antibiotics10050600815868734069329 Search in Google Scholar

96 Oliveira-Tintino C.D.M., Silva T.G.D. et al.: The 1,8-naphthyridines sulfonamides are NorA efflux pump inhibitors. J. Glob. Antimicrob. Resist. 24, 233–240 (2021) Oliveira-TintinoC.D.M. SilvaT.G.D. The 1,8-naphthyridines sulfonamides are NorA efflux pump inhibitors J. Glob. Antimicrob. Resist. 24 233 240 2021 10.1016/j.jgar.2020.11.02733385589 Search in Google Scholar

97 Pule C.M., Sampson S.L., Warren R.M., Black P.A., van Helden P.D., Victor T.C., Louw G.E.: Efflux pump inhibitors: targeting myco-bacterial efflux systems to enhance TB therapy. J. Antimicrob. Chemother. 71, 17–26 (2016) PuleC.M. SampsonS.L. WarrenR.M. BlackP.A. van HeldenP.D. VictorT.C. LouwG.E. Efflux pump inhibitors: targeting myco-bacterial efflux systems to enhance TB therapy J. Antimicrob. Chemother. 71 17 26 2016 10.1093/jac/dkv31626472768 Search in Google Scholar

98 Fenosa A., Fusté E., Ruiz L., Veiga-Crespo P., Vinuesa T., Guallar V., Villa T.G., Viñas M.: Role of TolC in Klebsiella oxytoca resistance to antibiotics. J. Antimicrob. Chemother. 63, 668–674 (2009) FenosaA. FustéE. RuizL. Veiga-CrespoP. VinuesaT. GuallarV. VillaT.G. ViñasM. Role of TolC in Klebsiella oxytoca resistance to antibiotics J. Antimicrob. Chemother. 63 668 674 2009 10.1093/jac/dkp02719240073 Search in Google Scholar

99 Anoushiravani M., Falsafi T., Niknam V.: Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori. J. Med. Microbiol. 58, 1309–1313 (2009) AnoushiravaniM. FalsafiT. NiknamV. Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori J. Med. Microbiol. 58 1309 1313 2009 10.1099/jmm.0.010876-019574414 Search in Google Scholar

100 Bhattacharyya T., Sharma A., Akhter J., Pathania R.: The small molecule IITR08027 restores the antibacterial activity of fluoroquinolones against multidrug-resistant Acinetobacter baumannii by efflux inhibition. Int. J. Antimicrob. Agents. 50, 219–226 (2017) BhattacharyyaT. SharmaA. AkhterJ. PathaniaR. The small molecule IITR08027 restores the antibacterial activity of fluoroquinolones against multidrug-resistant Acinetobacter baumannii by efflux inhibition Int. J. Antimicrob. Agents. 50 219 226 2017 10.1016/j.ijantimicag.2017.03.00528533185 Search in Google Scholar

101 Renau T.E., Ohta T. et al., Nakayama K.: Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42, 4928–4931 (1999) RenauT.E. OhtaT. NakayamaK. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin J. Med. Chem. 42 4928 4931 1999 10.1021/jm990459810585202 Search in Google Scholar

102 Gupta S., Cohen K.A., Winglee K., Maiga M., Diarra B., Bishai W.R.: Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis. Antimicrob. Agents. Chemother. 58, 574–576 (2014) GuptaS. CohenK.A. WingleeK. MaigaM. DiarraB. BishaiW.R. Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis Antimicrob. Agents. Chemother. 58 574 576 2014 10.1128/AAC.01462-13391072224126586 Search in Google Scholar

103 Bohnert J.A., Kern W.V.: Selected arylpiperazines are capable of reversing multi-drug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents. Chemother. 49, 849–852 (2005) BohnertJ.A. KernW.V. Selected arylpiperazines are capable of reversing multi-drug resistance in Escherichia coli overexpressing RND efflux pumps Antimicrob. Agents. Chemother. 49 849 852 2005 10.1128/AAC.49.2.849-852.200554722315673787 Search in Google Scholar

104 Stavri M., Piddock L.J.V., Gibbons S.: Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother. 59, 1247–1260 (2007) StavriM. PiddockL.J.V. GibbonsS. Bacterial efflux pump inhibitors from natural sources J. Antimicrob. Chemother. 59 1247 1260 2007 10.1093/jac/dkl46017145734 Search in Google Scholar

105 Kumar A., Qazi G.N. et al.: Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J. Antimicrob. Chemother. 61, 1270–1276 (2008) KumarA. QaziG.N. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus J. Antimicrob. Chemother. 61 1270 1276 2008 10.1093/jac/dkn08818334493 Search in Google Scholar

106 Chan B.C., Leung P.C. et al.: Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J. Ethnopharmacol. 137, 767–773 (2011) ChanB.C. LeungP.C. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase J. Ethnopharmacol. 137 767 773 2011 10.1016/j.jep.2011.06.03921782012 Search in Google Scholar

107 Fujita M., Shiota S., Kuroda T., Hatano T., Yoshida T., Mizushima T., Tsuchiya T.: Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 49, 391–396 (2005) FujitaM. ShiotaS. KurodaT. HatanoT. YoshidaT. MizushimaT. TsuchiyaT. Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus Microbiol. Immunol. 49 391 396 2005 10.1111/j.1348-0421.2005.tb03732.x15840965 Search in Google Scholar

108 Stermitz F.R., Lorenz P., Tawara J.N., Zenewicz L.A., Lewis K.: Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U S A. 97, 1433–1437 (2000) StermitzF.R. LorenzP. TawaraJ.N. ZenewiczL.A. LewisK. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proc. Natl. Acad. Sci. U S A. 97 1433 1437 2000 10.1073/pnas.0305405972645110677479 Search in Google Scholar

109 AlMatar M., Albarri O., Makky E.A., Köksal F.: Efflux pump inhibitors: new updates. Pharmacol. Rep. PR. 73, 1–16 (2021) AlMatarM. AlbarriO. MakkyE.A. KöksalF. Efflux pump inhibitors: new updates Pharmacol. Rep. PR. 73 1 16 2021 10.1007/s43440-020-00160-932946075 Search in Google Scholar

110 SudanoRoccaro A., Blanco A.R., Giuliano F., Rusciano D., Enea V.: Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob. Agents. Chemother. 48, 1968–1973 (2004) SudanoRoccaroA. BlancoA.R. GiulianoF. RuscianoD. EneaV. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells Antimicrob. Agents. Chemother. 48 1968 1973 2004 10.1128/AAC.48.6.1968-1973.200441560115155186 Search in Google Scholar

111 Joshi P., Kumar A. et al.: Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs. Med. Chem. Comm. 5, 1540–1547 (2014) JoshiP. KumarA. Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs Med. Chem. Comm. 5 1540 1547 2014 10.1039/C4MD00196F Search in Google Scholar

112 Negi N., Prakash P., Gupta M.L., Mohapatra T.M.: Possible role of curcumin as an efflux pump inhibitor in multi drug resistant clinical isolates of Pseudomonas aeruginosa. J. Clin. Diagn. Res. JCDR. 8, DC04–DC07 (2014) NegiN. PrakashP. GuptaM.L. MohapatraT.M. Possible role of curcumin as an efflux pump inhibitor in multi drug resistant clinical isolates of Pseudomonas aeruginosa J. Clin. Diagn. Res. JCDR. 8 DC04 DC07 2014 10.7860/JCDR/2014/8329.4965425315825478340 Search in Google Scholar

113 Roy S., Kumari N., Pahwa S., Agrahari U., Bhutani K., Jachak S., Nandanwar H.: NorA efflux pump inhibitory activity of coumarins from Mesua ferrea. Fitoterapia, 90, 140–150 (2013) RoyS. KumariN. PahwaS. AgrahariU. BhutaniK. JachakS. NandanwarH. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea Fitoterapia 90 140 150 2013 10.1016/j.fitote.2013.07.01523892000 Search in Google Scholar

114 Oluwatuyi M., Kaatz G.W., Gibbons S.: Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry, 65, 3249–3254 (2004) OluwatuyiM. KaatzG.W. GibbonsS. Antibacterial and resistance modifying activity of Rosmarinus officinalis Phytochemistry 65 3249 3254 2004 10.1016/j.phytochem.2004.10.00915561190 Search in Google Scholar

115 Lorenzi V., Muselli A., Bernardini A.F., Berti L., Pagès J.M., Amaral L., Bolla J.M.: Geraniol restores antibiotic activities against multidrug-resistant isolates from Gram-negative species. Antimicrob. Agents. Chemother. 53, 2209–2211 (2009) LorenziV. MuselliA. BernardiniA.F. BertiL. PagèsJ.M. AmaralL. BollaJ.M. Geraniol restores antibiotic activities against multidrug-resistant isolates from Gram-negative species Antimicrob. Agents. Chemother. 53 2209 2211 2009 10.1128/AAC.00919-08 Search in Google Scholar

116 Dwivedi G.R., Tyagi R., Sanchita., Tripathi S., Pati S., Srivastava S.K., Darokar M.P., Sharma A.: Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa. J. Biomol. Struct. Dyn. 36, 4270–284 (2018) DwivediG.R. TyagiR. Sanchita TripathiS. PatiS. SrivastavaS.K. DarokarM.P. SharmaA. Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa J. Biomol. Struct. Dyn. 36 4270 284 2018 10.1080/07391102.2017.1413424 Search in Google Scholar

117 Chevalier J., Atifi S., Eyraud A., Mahamoud A., Barbe J., Pagès J.M.: New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. J. Med. Chem. 44, 4023–4026 (2001) ChevalierJ. AtifiS. EyraudA. MahamoudA. BarbeJ. PagèsJ.M. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains J. Med. Chem. 44 4023 4026 2001 10.1021/jm010911z Search in Google Scholar

118 Kaatz G.W., Moudgal V.V., Seo S.M., Hansen J.B., Kristiansen J.E.: Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Int. J. Antimicrob. Agents. 22, 254–261 (2003) KaatzG.W. MoudgalV.V. SeoS.M. HansenJ.B. KristiansenJ.E. Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus Int. J. Antimicrob. Agents. 22 254 261 2003 10.1016/S0924-8579(03)00220-6 Search in Google Scholar

119 Opperman T.J., Nguyen S.T.: Recent advances toward a molecular mechanism of efflux pump inhibition. Front. Microbiol. 6, 421 (2015) OppermanT.J. NguyenS.T. Recent advances toward a molecular mechanism of efflux pump inhibition Front. Microbiol. 6 421 2015 10.3389/fmicb.2015.00421441985925999939 Search in Google Scholar

120 Mahmood H.Y., Jamshidi S., Sutton J.M., Rahman K.M.: Current advances in developing inhibitors of bacterial multi-drug efflux pumps. Curr. Med. Chem. 23, 1062–1081 (2016) MahmoodH.Y. JamshidiS. SuttonJ.M. RahmanK.M. Current advances in developing inhibitors of bacterial multi-drug efflux pumps Curr. Med. Chem. 23 1062 1081 2016 10.2174/0929867323666160304150522542565626947776 Search in Google Scholar

121 Vargiu A.V., Ruggerone P., Opperman T.J., Nguyen S.T., Nikaido H.: Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Antimicrob. Agents. Chemother. 58, 6224–6234 (2014) VargiuA.V. RuggeroneP. OppermanT.J. NguyenS.T. NikaidoH. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors Antimicrob. Agents. Chemother. 58 6224 6234 2014 10.1128/AAC.03283-14418798725114133 Search in Google Scholar

122 Fontaine F., Héquet A., Voisin-Chiret A.S., Bouillon A., Lesnard A., Cresteil T., Jolivalt C., Rault S.: Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives. Eur. J. Med. Chem. 95, 185–198 (2015) FontaineF. HéquetA. Voisin-ChiretA.S. BouillonA. LesnardA. CresteilT. JolivaltC. RaultS. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives Eur. J. Med. Chem. 95 185 198 2015 10.1016/j.ejmech.2015.02.05625817769 Search in Google Scholar

123 Zeng B., Wang H., Zou L., Zhang A., Yang X., Guan Z.: Evaluation and target validation of indole derivatives as inhibitors of the AcrAB-TolC efflux pump. Biosci. Biotechnol. Biochem. 74, 2237–2241 (2010) ZengB. WangH. ZouL. ZhangA. YangX. GuanZ. Evaluation and target validation of indole derivatives as inhibitors of the AcrAB-TolC efflux pump Biosci. Biotechnol. Biochem. 74 2237 2241 2010 10.1271/bbb.10043321071837 Search in Google Scholar

124 Rana T., Singh S., Kaur N., Pathania K., Gaur U.: A review on efflux pump inhibitors of medically important bacteria from plant sources. Int. J. Pharm. Sci. Rev. Res. 26, 101–111 (2014) RanaT. SinghS. KaurN. PathaniaK. GaurU. A review on efflux pump inhibitors of medically important bacteria from plant sources Int. J. Pharm. Sci. Rev. Res. 26 101 111 2014 Search in Google Scholar

125 Abbas H., Shaker G., Khattab R., Askoura M.: A new role of metformin as an efflux pump inhibitor in Klebsiella pneumonia. J. Microbiol. Biotechnol. Food Sci. 11, e4232–e4232 (2021) AbbasH. ShakerG. KhattabR. AskouraM. A new role of metformin as an efflux pump inhibitor in Klebsiella pneumonia J. Microbiol. Biotechnol. Food Sci. 11 e4232 e4232 2021 10.15414/jmbfs.4232 Search in Google Scholar

126 Lee M.D., Galazzo J.L., Staley A.L., Lee J.C., Warren M.S., Fuernkranz H., Chamberland S., Lomovskaya O., Miller G.H.: Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farm. Soc. Chim. Ital. 1989. 56, 81–85 (2001) LeeM.D. GalazzoJ.L. StaleyA.L. LeeJ.C. WarrenM.S. FuernkranzH. ChamberlandS. LomovskayaO. MillerG.H. Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance Farm. Soc. Chim. Ital. 1989. 56 81 85 2001 10.1016/S0014-827X(01)01002-3 Search in Google Scholar

127 Bhardwaj A.K., Mohanty P.: Bacterial efflux pumps involved in multi-drug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy. Recent. Patents. Anti-Infect. Drug. Disc. 7, 73–89 (2012) BhardwajA.K. MohantyP. Bacterial efflux pumps involved in multi-drug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy Recent. Patents. Anti-Infect. Drug. Disc. 7 73 89 2012 10.2174/15748911279982971022353004 Search in Google Scholar

128 Ferrer-Espada R., Shahrour H., Pitts B., Stewart P.S., Sánchez-Gómez S., Martínez-de-Tejada G.: A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains. Sci. Rep. 9, 3452 (2019) Ferrer-EspadaR. ShahrourH. PittsB. StewartP.S. Sánchez-GómezS. Martínez-de-TejadaG. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains Sci. Rep. 9 3452 2019 10.1038/s41598-019-39659-4640111930837499 Search in Google Scholar

129 Keirstead N.D., Kern G. et al.: Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. Toxicol. Sci. 137, 278–291 (2014) KeirsteadN.D. KernG. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers Toxicol. Sci. 137 278 291 2014 10.1093/toxsci/kft24724189134 Search in Google Scholar

130 Rathi E., Kumar A., Kini S.G.: Computational approaches in efflux pump inhibitors: current status and prospects. Drug. Discov. Today. 25, 1883–1890 (2020) RathiE. KumarA. KiniS.G. Computational approaches in efflux pump inhibitors: current status and prospects Drug. Discov. Today. 25 1883 1890 2020 10.1016/j.drudis.2020.07.01132712312 Search in Google Scholar

131 Pagès J-M., Amaral L., Fanning S.: An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat Gram-negative resistant bacteria. Curr. Med. Chem. 18, 2969–2980 (2011) PagèsJ-M. AmaralL. FanningS. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat Gram-negative resistant bacteria Curr. Med. Chem. 18 2969 2980 2011 10.2174/09298671179615046921651484 Search in Google Scholar

132 Mehla J., Zgurskaya H.I. et al.: Predictive rules of efflux inhibition and avoidance in Pseudomonas aeruginosa. mBio. 12, 02785–20 (2021) MehlaJ. ZgurskayaH.I. Predictive rules of efflux inhibition and avoidance in Pseudomonas aeruginosa mBio. 12 02785 20 2021 10.1128/mBio.02785-20784564333468691 Search in Google Scholar